EV Nickel Inc. | WebDisclosure

BRIEF

published on 12/12/2024 at 15:30, 1 year 3 months ago

EV Nickel annonce des découvertes minéralogiques prometteuses dans la zone Gemini

Programme D'exploration Nickel Électrique Zone Gémeaux Résultats Minéralogiques Sulfures De Nickel
BRIEF

published on 12/12/2024 at 15:30, 1 year 3 months ago

EV Nickel Reports Promising Mineralogical Findings in Gemini Zone

Exploration Program EV Nickel Gemini Zone Mineralogical Results Nickel Sulfides
PRESS RELEASE

published on 12/12/2024 at 15:25, 1 year 3 months ago

EV Nickel Announces Positive Mineralogical Results For New Large-Scale Zone
EV Nickel Inc. announces QEMSCAN analysis results on new large-scale zone "Gemini Zone" confirming presence of magmatic sulfides. Focus shifting to higher-grade concentrate potential in 2025 exploration program

EV Nickel Inc. Gemini Zone QEMSCAN Analysis Magmatic Sulfides 2025 Exploration Program
BRIEF

published on 11/21/2024 at 11:35, 1 year 4 months ago

Offre publique d'achat de Zentiva sur APONTIS PHARMA : l'exigence d'acceptation minimale est levée

Offre Publique D'achat APONTIS PHARMA Retrait De La Liste Zentiva Acceptation Des Actionnaires
BRIEF

published on 11/21/2024 at 11:35, 1 year 4 months ago

Zentiva's Tender Offer for APONTIS PHARMA: Minimum Acceptance Requirement Waived

Tender Offer Delisting APONTIS PHARMA Zentiva Shareholder Acceptance
PRESS RELEASE

published on 11/21/2024 at 11:30, 1 year 4 months ago

APONTIS PHARMA AG: Condition of Minimum Acceptance in Zentiva’s Voluntary Public Purchase Offer Waived
APONTIS PHARMA AG waives minimum acceptance condition in Zentiva's public purchase offer. Around 60% shares tendered. Management recommends acceptance. Cash consideration offers premium

APONTIS PHARMA Premium Cash Consideration Public Purchase Offer Zentiva
PRESS RELEASE

published on 11/13/2024 at 11:21, 1 year 4 months ago

Original-Research: APONTIS PHARMA AG (von Montega AG): Verkaufen (zuvor: Halten)
Montega AG stuft APONTIS PHARMA AG von Verkaufen auf Halten herab und senkt das Kursziel auf 10,00 EUR. Umsatzprognose gesenkt auf 48,7 Mio. EUR aufgrund verzögerter Wirkung der neuen Vertriebsstrategie

Montega AG Umsatzprognose APONTIS PHARMA AG Vertriebsstrategie Verkaufen
BRIEF

published on 11/12/2024 at 13:05, 1 year 4 months ago

EV Nickel annonce des résultats élevés en nickel et en métaux précieux

Métaux Précieux Programme D'exploration Minéralisation De Nickel Zone C De CarLang Analyse Minéralogique
BRIEF

published on 11/12/2024 at 13:05, 1 year 4 months ago

EV Nickel Reports High Nickel and Precious Metal Assays

Exploration Program Precious Metals Nickel Mineralization CarLang C Zone Mineralogical Analysis
PRESS RELEASE

published on 11/12/2024 at 13:00, 1 year 4 months ago

EV Nickel Reports Precious Metals Assays Associated with Elevated Nickel Mineralization in Hole Ev24-Car08 on the CarLang C Zone
EV Nickel Inc. announces significant nickel mineralization with high PGM values in CarLang C area, indicating potential for magmatic sulphide source. Exploration and testing programs ongoing

Exploration Program EV Nickel Inc. Nickel Mineralization PGM Values CarLang C Area

Published on 03/26/2026 at 21:00, 16 minutes ago

Worksport Reports Record FY 2025 Results, Issues $35M–$42M 2026 Revenue Guidance; Targets Initial Cash Flow Positivity
Published on 03/26/2026 at 21:00, 16 minutes ago

Rocky Shore Closes Acquisition of Additional Mining Claims
Published on 03/26/2026 at 16:20, 4 hours 56 minutes ago

ACCESS Newswire Upgrades the ACCESS Platform to Include Social Monitoring to Track Brand Conversations Across Major Social Platforms
Published on 03/26/2026 at 14:05, 7 hours 11 minutes ago

SouthGobi Announces Profit Warning
Published on 03/26/2026 at 13:00, 8 hours 16 minutes ago

Prospect Ridge Strengthens Technical Team with Appointment of Phil Smerchanski as Senior Technical Advisor

View all ACCESSWIRE

Published on 03/26/2026 at 20:48, 28 minutes ago

Dermapharm Holding SE repurchases 4,299,190 shares under its public share buyback offer
Published on 03/26/2026 at 19:20, 1 hour 56 minutes ago

Critical Path Institute Launches 'One to Millions' to Reshape the Future of Individualized Medicine at Global Scale
Published on 03/26/2026 at 19:13, 2 hours 3 minutes ago

Director Declaration
Published on 03/26/2026 at 19:09, 2 hours 6 minutes ago

2CRSi SA: Résultats 1er Semestre 2025/26 : Chiffre d'Affaires 204,7 M€ (x9,8) EBITDA de 9,6 M€ (x4,6)
Published on 03/26/2026 at 19:09, 2 hours 6 minutes ago

2CRSi SA: First Half 2025/26 Results: Revenue of €204.7 million (x9.8) EBITDA of €9.6 million (x4.6)

View all EQS

Published on 03/26/2026 at 18:17, 2 hours 59 minutes ago

Eiffage se renforce au capital de Getlink et porte sa participation à 29,40 % du capital
Published on 03/26/2026 at 18:17, 2 hours 59 minutes ago

Eiffage strengthens its position in Getlink capital
Published on 03/26/2026 at 18:00, 3 hours 16 minutes ago

Arrêté des comptes au 31 décembre 2025 et perspectives 2026
Published on 03/26/2026 at 18:00, 3 hours 16 minutes ago

Calendrier financier 2026
Published on 03/26/2026 at 18:00, 3 hours 16 minutes ago

LABORATOIRES EUROMEDIS - Fin du contrat de liquidité

View all LES ECHOS COMFI WIRE

News